Behcet's syndrome: clinical, immunological and therapeutic evaluation of 17 patients.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001168:Arthritis / Q000209:etiology; D001323:Autoantibodies / Q000032:analysis; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D001768:Blister / Q000209:etiology; D002648:Child; D003165:Complement System Proteins / Q000032:analysis; D003450:Cryoglobulins / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000209:etiology; D010629:Phenformin / Q000627:therapeutic use; D012883:Skin Ulcer / Q000209:etiology
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D003450:Cryoglobulins; D007136:Immunoglobulins; D003520:Cyclophosphamide; D003165:Complement System Proteins; D005032:Ethylestrenol; D010629:Phenformin